These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26125933)

  • 1. Expression and clinical value of the soluble major histocompatibility complex class I-related chain A molecule in the serum of patients with renal tumors.
    Zhao YK; Jia CM; Yuan GJ; Liu W; Qiu Y; Zhu QG
    Genet Mol Res; 2015 Jun; 14(2):7233-40. PubMed ID: 26125933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
    Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
    Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of soluble major histocompatibility complex class I chain-related a in renal cell carcinoma patients.
    Qiu Y; Zhao YK; Yuan GJ; Zhu QG
    Asian Pac J Cancer Prev; 2013; 14(10):5651-5. PubMed ID: 24289557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble MICA in malignant diseases.
    Holdenrieder S; Stieber P; Peterfi A; Nagel D; Steinle A; Salih HR
    Int J Cancer; 2006 Feb; 118(3):684-7. PubMed ID: 16094621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble major histocompatibility complex class I-related chain A in sera of patients with oral squamous cell carcinoma].
    Li C; Shi F; Yang D; Wang J; Jian X; Jiang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):168-72. PubMed ID: 22561434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of serum sMICA levels in non-small cell lung cancer.
    Wang LP; Niu H; Xia YF; Han YL; Niu P; Wang HY; Zhou QL
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2226-30. PubMed ID: 26166647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Molina B; Bernardo-Rodríguez MJ; Alvarez-López R; Pascual D; Astudillo A; Martínez-Borra J; Lambert JL; González S; López-Larrea C
    Transplantation; 2006 Aug; 82(3):354-61. PubMed ID: 16906033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications and diagnostic usefulness of correlation between soluble major histocompatibility complex class I chain-related molecule a and protumorigenic cytokines in pancreatic ductal adenocarcinoma.
    Chung HW; Jang S; Lim JB
    Cancer; 2013 Jan; 119(1):233-44. PubMed ID: 22736451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble major histocompatibility complex class I-related chain A protein reduced NKG2D expression on natural killer and T cells from patients with prolactinoma and non-secreting pituitary adenoma.
    Ma L; Li G; Su Y; He Q; Zhang C; Zhang J
    J Clin Neurosci; 2010 Feb; 17(2):241-7. PubMed ID: 20045334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between major histocompatibility complex class I chain-related antigens A (MICA)-129 gene polymorphism, soluble MICA level and ulcerative colitis].
    Zhao J; Jiang Y; Lei Y; Chen LP; Yi FM; Wang CG; Zou KF; Xia B
    Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):311-5. PubMed ID: 21600151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.
    Jiang X; Huang JF; Huo Z; Zhang Q; Jiang Y; Wu X; Li Y; Jiang G; Zeng L; Yan XX; Yu P; Cao R
    BMC Immunol; 2012 Nov; 13():62. PubMed ID: 23181907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease.
    Ben Chaaben A; Ouni N; Douik H; Ayari F; Abaza H; Mamoghli T; Harzallah L; Fortier C; Boukouaci W; Krishnamoorthy R; Charron D; Gara S; Guemira F; Tamouza R
    Immunol Invest; 2020 Jul; 49(5):498-509. PubMed ID: 31814472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sMICA as biomarker in detection of non-small-cell lung carcinoma.
    Xing S; Zhu Y; Sun Y
    Br J Biomed Sci; 2018 Jan; 75(1):50-52. PubMed ID: 29182468
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.
    Li JJ; Pan K; Gu MF; Chen MS; Zhao JJ; Wang H; Liang XT; Sun JC; Xia JC
    Chin J Cancer; 2013 Mar; 32(3):141-8. PubMed ID: 22704489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
    Rebmann V; Schütt P; Brandhorst D; Opalka B; Moritz T; Nowrousian MR; Grosse-Wilde H
    Clin Immunol; 2007 Apr; 123(1):114-20. PubMed ID: 17218152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Phospho-p38, Matrix Metalloproteinase 9, and Major Histocompatibility Complex Class I Chain-Related Molecule A Expression in Pituitary Adenomas Demonstrates a New Mechanism of Pituitary Adenoma Immune Escape.
    Han X; Geng X; Li Z; Chen Z; Liu Y; Liu P; Wang Q; Li C; Ai D; Li Z
    World Neurosurg; 2019 Mar; 123():e116-e124. PubMed ID: 30458325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma.
    Kushlinskii NE; Gershtein ES; Morozov AA; Goryacheva IO; Filipenko ML; Alferov AA; Bezhanova SD; Bazaev VV; Kazantseva IA
    Bull Exp Biol Med; 2019 Jan; 166(3):353-357. PubMed ID: 30627905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of membrane/soluble MHC class I chain-related molecule A and NKG2D receptor in osteosarcoma and its clinical significance].
    Xiao P; Xue L; Che LH; Wu HX; Qiao H
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):596-9. PubMed ID: 18070447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.